RT @CircImaging: Over the past 41 years, death due to ischemic heart disease did not decline in countries with low socioeconomic developmen….

🙏🙏Incredibly thankful to @almallahmo and Dr. Al Rifai for their supervision & guidance on this; and to my brilliant colleague @MariaAlwan_ 🙏🙏. And thank you to @EHJCVIEiC for allowing us to share our findings!.

Patients with a normal-ish EF could be further stratified as being at a *truly* low-risk of events or at intermediate risk depending on their rest flow. In contrast, patients with a depressed EF had a uniformly high rate of events regardless.

Our hypothesis was that an elevated amount of myocardial blood flow at rest, which PET can measure, would predict adverse event rates. And it did, esp. in patients with a normal EF at rest.

First, some background. Prior data indicated that the myocardium of patients with LVH/HFpEF receives an excessive amount of blood flow at rest (. There is also mechanistic data that medications effective in HFpEF reduce this (

1/4🧵. In patients undergoing cardiac stress testing w/ PET, does rest flow matter❓. In an analysis of >8k patients, we find that it does, esp. in patients with a preserved EF. Link📜: @almallahmo @MariaAlwan_ @MyASNC @MethodistHosp @EHJCVIEiC

RT @fiyyazAJ: 𝐃𝐒𝐄 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐎𝐑𝐁𝐈𝐓𝐀-𝟐: Stress echo ischemia identifies who 𝘳𝘦𝘢𝘭𝘭𝘺 benefits from PCI. 📖 𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐧 #𝐉𝐀𝐂𝐂: https://t.….

RT @MalakMunirMD: An incredible experience at #DDW2025! Privileged to share our work on #pancreaticcancer, Fatty Pancreas, and #colorectalc….

RT @NutritionMadeS3: New genetic analysis in 200k people over 14 years. ▶️apoB + lp(a) best capture lipid-mediated CV risk. ▶️LDL particle….

RT @CircAHA: Intensive LDL-C lowering with Evolocumab may lead to greater relative reduction in cardiovascular events in patients with auto….

RT @Ahmadkassar7: Just in time for #HRS2025‼️. Excited to share our latest paper published in @AmericanHeartJ and honored to be first co-au….

RT @CardioMDPhD: We have an opening for an advanced imaging fellowship position available starting July 2025 at @MonteHeart. Applicants tha….

RT @JNCjournal: PET-derived global MFR is inversely associated with subsequent cardiovascular outcomes in all BMI categories @almallahmo @H….

RT @AbushoukMD: Read our latest work in @CircIntv led by Dr Zmaili and supervised by Dr @tavrkapadia.

RT @HusamSalah: 🧵Renal Denervation (RDN) for Hypertension – .A meta-analysis of 12 sham-controlled RCTs in @ehjopen ..

🙏Immensely grateful to Drs. @MartinMaronMD @EthanRowin and Dr. Barry Maron for their guidance and mentorship on this work🙏.

How have HCM mortality rates changed before and after COVID ❓. 1⃣ Prior to COVID, mortality rates declined by ~ half📉.2⃣ After COVID, mortality rates increased by ~30%, partially undoing some of the prior reductions in HCM mortality.📈. Open access📜:

RT @DmitryAbramovMD: Our paper in @CircOutcomes, highlighting differences in CV mortality reporting between CDC WONDER and Global Burden of….

RT @jad_zeitoun: Happy to present our abstract on the importance of multimodality imaging in the evaluation and management of paravalvular….

RT @ahmadyaman2000: Wrapped up an incredible #ACC2025! Honored to present two posters about CMR and CCT readers. Grateful for @almallahmo….